您的位置: 首页 > 农业专利 > 详情页

methods for providing adjuvant treatment to a patient with an earlier diagnosis of melanoma that has been resected and to increase relapse-free survival (rfs) of a patient following melanoma resection;
专利权人:
GLAXOSMITHKLINE LLC
发明人:
Peter F. Lebowitz,Sylvie Laquerre
申请号:
BR112015004578
公开号:
BR112015004578A2
申请日:
2013.08.30
申请国别(地区):
BR
年份:
2017
代理人:
摘要:
1/1 summary â € œmethods to provide adjunctive treatment to a patient with an earlier diagnosis of melanoma that has been resected and to increase a patientâ € ™ s non-relapsing survival (rfs) after melanoma resection, and, composition. The present invention relates to a method of providing adjuvant treatment to a human patient which comprises administering to a patient as such therapeutically effective doses of dabrafenib and trametinib for a period of time sufficient to increase survival without relapse (rfs).1 / 1 resumo “mã‰todos para fornecer tratamento adjuvante a um paciente com uma diagnose anterior de melanoma que foi ressectado e para aumentar sobrevivãšncia sem recaã�da (rfs) de um paciente depois de ressecã‡ãƒo de melanoma, e, composiã‡ãƒoâ€� a presente invenã§ã£o refere-se a um mã©todo de fornecer tratamento adjuvante para um paciente humano, que compreende administrar em um paciente como essas doses terapeuticamente efetivas de dabrafenib e trametinib por um perã­odo de tempo suficiente para aumentar sobrevivãªncia sem recaã­da (rfs).
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充